DATATRAK International, Inc. (OTCQX: DTRK) is a worldwide technology
services company delivering unified eClinical® solutions and related services
designed to safely accelerate every drug, biologic and device from concept to
cure. The company’s proprietary DATATRAK ONE® Unified Experience™ platform
provides users with an all-in one clinical enterprise solution complete with
all of the necessary components to effectively design, deliver and manage
clinical trials. DATATRAK’s groundbreaking software solution currently supports
preclinical through phase IV drug and device studies in multiple languages
around the world.
Earlier this month, DATATRAK built on its industry-leading software
suite through the introduction of UX CTMS 360™. Using this revolutionary
startup solution, clinical trials can be initiated at the click of a button
without the need for programming expertise. By effectively eliminating the
risks and time required to integrate data across multiple systems, the
company’s clinical trial management system provides clients with an immediate
return on investment.
“The industry has struggled long enough with data silos and expensive
third party consulting fees,” Laurence P. Birch, chairman and chief executive
officer of DATATRAK, stated in a news release. “With the introduction of UX
CTMS 360, we strip away that complexity and expense… [providing] an immediate
view of all clinical and operational data across studies.”
In recent months, DATATRAK has made significant progress toward
expanding its market share in the life sciences market. In the first quarter of
2015, the company recorded a 35 percent year-over-year increase in new contract
sales as a result of continued investment in sales and marketing efforts. This
increase in contract sales resulted in a backlog of $27.8 million, an increase
of 7 percent over the end of 2014. In April, the company laid the groundwork
for continued improvement in the future by opening its Chicago office,
expanding its physical presence in one of the country’s leading life sciences
markets.
“The success we’re seeing in new contract sales is a positive for the
business overall,” continued Birch. “New clients often become our most
dedicated partners, setting the stage for future revenue growth.”
For more information, visit www.datatrak.com
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
